Bärbel Spies‐Weisshart

Ponatinib may overcome resistance of <scp>FLT</scp>3‐<scp>ITD</scp> harbouring additional point mutations, notably the previously refractory <scp>F</scp>691I mutation

Elisabeth Zirm, Bärbel Spies‐Weisshart, Florian H. Heidel et al. · British Journal of Haematology · 2012 · 51 citations

Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemia

Ulf Schnetzke, Bärbel Spies‐Weisshart, Olaposi Yomade et al. · Genes and Immunity · 2014 · 48 citations

Inflammation, Toll-like Receptors, Immunogenetics +11

Isoform localization of Dectin‐1 regulates the signaling quality of anti‐fungal immunity

Mike Fischer, Jörg P. Müller, Bärbel Spies‐Weisshart et al. · European Journal of Immunology · 2017 · 32 citations · Full text

Impact of NOD2 polymorphisms on infectious complications following chemotherapy in patients with acute myeloid leukaemia

Olaposi Yomade, Bärbel Spies‐Weisshart, Anita Glaser et al. · Annals of Hematology · 2013 · 14 citations

Hematological Malignancy, Nod2 Polymorphisms, Medicine +10

The E3 ubiquitin ligase TRAF2 can contribute to TNF-α resistance in FLT3-ITD-positive AML cells

Ulf Schnetzke, Mike Fischer, Bärbel Spies‐Weisshart et al. · Leukemia Research · 2013 · 13 citations

Signal Transduction, Flt3-itd-positive Aml Cells, Tnf-α Resistance +9